Page 60 - ITPS-7-2
P. 60
INNOSC Theranostics and
Pharmacological Sciences Cardiac metabolism in health and disease
doi: 10.1161/01.cir.100.18.1847 82. Berthiaume JM, Young ME, Chen X, McElfresh TA, Yu X,
Chandler MP. Normalizing the metabolic phenotype
78. Kato T, Niizuma S, Inuzuka Y, et al. Analysis of metabolic after myocardial infarction: Impact of subchronic high fat
remodeling in compensated left ventricular hypertrophy feeding. J Mol Cell Cardiol. 2012;53(1):125-133.
and heart failure. Circ Heart Fail. 2010;3(3):420-430.
doi: 10.1016/j.yjmcc.2012.04.005
doi: 10.1161/CIRCHEARTFAILURE.109.888479
83. Berthiaume JM, Bray MS, McElfresh TA, et al. The
79. Degens H, de Brouwer KF, Gilde AJ, et al. Cardiac fatty acid myocardial contractile response to physiological stress
metabolism is preserved in the compensated hypertrophic improves with high saturated fat feeding in heart failure. Am
rat heart. Basic Res Cardiol. 2006;101(1):17-26. J Physiol Heart Circ Physiol. 2010;299(2):H410-H421.
doi: 10.1007/s00395-005-0549-0 doi: 10.1152/ajpheart.00270.2010
80. Akki A, Smith K, Seymour AM. Compensated cardiac 84. Reid IR, Birstow SM, Bolland MJ, Reid IR, Birstow SM,
hypertrophy is characterised by a decline in palmitate Bolland MJ. Calcium and cardiovascular disease. Endocrinol
oxidation. Mol Cell Biochem. 2008;311(1-2):215-224. Metab (Seoul). 2017;32(3):339-349.
doi: 10.1007/s11010-008-9711-y doi: 10.3803/EnM.2017.32.3.339
81. Dai DF, Hsieh EJ, Liu Y, et al. Mitochondrial proteome 85. Sutanto H, Lyon A, Lumens J, Schotten U, Dobrev D,
remodelling in pressure overload-induced heart failure: Heijman J. Cardiomyocyte calcium handling in health and
The role of mitochondrial oxidative stress. Cardiovasc Res. disease: Insights from in vitro and in silico studies. Prog
2012;93(1):79-88. Biophys Mol Biol. 2020;157:54-75.
doi: 10.1093/cvr/cvr274 doi: 10.1016/j.pbiomolbio.2020.02.008
Volume 7 Issue 2 (2024) 11 doi: 10.36922/itps.2302

